Presidential Symposium I
Invited Discussant LBA5_PR
Date
28 Sep 2019Session
Presidential Symposium IPresenters
Pasi JänneAuthors
P.A. JänneAuthor affiliations
- Lowe Center For Thoracic Oncology, Dana Farber Cancer Institute, 02215 - Boston/US
Resources
Resources from the same session
4627 - Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)
Presenter: Antonio González Martín
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
3955 - Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev
Presenter: Isabelle Ray-Coquard
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
2772 - VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC)
Presenter: Robert Coleman
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
7128 - Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 Part 1 final analysis
Presenter: Solange Peters
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
567 - Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis
Presenter: Suresh Ramalingam
Session: Presidential Symposium I
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA1 and LBA2_PR
Presenter: Ana Oaknin
Session: Presidential Symposium I
Resources:
Slides
Webcast
Invited Discussant LBA3
Presenter: Mansoor Raza Mirza
Session: Presidential Symposium I
Resources:
Slides
Webcast
Invited Discussant LBA4_PR
Presenter: Sanjay Popat
Session: Presidential Symposium I
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.